The present invention provides compounds of Formula (I):
or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
本发明提供了式(I)的化合物:或其立体异构体、互变异构体、药用盐、溶剂化物或前药,其中所有变量均如本文所述。这些化合物是选择性的LPA受体
抑制剂。